GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

BAY 3389934   Click here for help

GtoPdb Ligand ID: 13845

Synonyms: BAY-3389934 | BAY3389934 | example 1 [US20230391761A1]
Compound class: Synthetic organic
Comment: The chemical structure of BAY 3389934 was disclosed during the 'First Time disclosures' session at the ACS Spring 2025 meeting in San Diego [2]. This matches one of the S-alaninate derived compounds claimed in patent US20230391761A1 as dual factor IIa/Xa inhibitors for the treatment of thrombotic/thromboembolic disorders and/or complications [1]. It is optimised for short duration of action, to enable strict control of anticoagulant activity in patients in critical care units.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 12
Hydrogen bond donors 3
Rotatable bonds 14
Topological polar surface area 191.39
Molecular weight 624.13
XLogP 0.08
No. Lipinski's rules broken 3

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCC1=C(C=CC=C1N2CC[C@@H](C2=O)O)S(=O)(=O)N[C@@H](CNC(=O)C3=CC=C(Cl)S3)C(=O)OCCC4=NC=CN4C
Isomeric SMILES CCC1=C(C=CC=C1S(=O)(=O)N[C@@H](CNC(=O)C2=CC=C(Cl)S2)C(=O)OCCC3=NC=CN3C)N4CC[C@H](O)C4=O
InChI InChI=1S/C26H30ClN5O7S2/c1-3-16-18(32-12-9-19(33)25(32)35)5-4-6-21(16)41(37,38)30-17(15-29-24(34)20-7-8-22(27)40-20)26(36)39-14-10-23-28-11-13-31(23)2/h4-8,11,13,17,19,30,33H,3,9-10,12,14-15H2,1-2H3,(H,29,34)/t17-,19-/m0/s1
InChI Key UHRIYOJEACOYON-HKUYNNGSSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Beck H, Mesch S, Vakalopoulos A, Pfaff N, Zimmermann S, Follmann M, Kersten E, Levilain G, Partikel K, Broehl AP et al.. (2023)
Substituted s-alaninate derivatives.
Patent number: US20230391761A1. Assignee: Bayer AG. Priority date: 11/08/2023. Publication date: 07/12/2023.
2. Nordqvist A, Brånalt J, Winiwarter S, Petersen J, Eriksson AW, Liljeblad M, Janzén D, Miliotis T, Carlsson ET, Liu J et al.
AZD2389, a first in class candidate drug for the treatment of metabolic dysfunction-associated steatohepatitis.
Accessed on 03/04/2025. Modified on 03/04/2025. acs.digitellinc.com, https://acs.digitellinc.com/p/s/azd2389-a-first-in-class-candidate-drug-for-the-treatment-of-metabolic-dysfunction-associated-steatohepatitis-622940